AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Essential Maintenance
: All Authorea-powered sites will be offline 4pm-6pm EDT Tuesday 28 May for essential maintenance.
We apologise for any inconvenience.
Christine Galant
Public Documents
1
Larotrectinib in a NTRK-rearranged soft tissue sarcoma in the neoadjuvant setting: a...
Catherine Percy
and 4 more
October 13, 2020
NTRK gene-fusions are rare but can occur in diverse cancers. The NTRK inhibitor larotrectinib is newly approved by the FDA. This paper reports the first case of a man with a NTRK-rearranged soft tissue sarcoma treated with larotrectinib in the neoadjuvant setting, in Belgium, to avoid limb amputation.